UBS Group’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Sell |
1,582,750
-229,625
| -13% | -$1.86M | ﹤0.01% | 2222 |
|
|
2025
Q1 | $15.2M | Buy |
1,812,375
+146,850
| +9% | +$1.23M | ﹤0.01% | 2010 |
|
|
2024
Q4 | $13.2M | Sell |
1,665,525
-20,107,524
| -92% | -$159M | ﹤0.01% | 2109 |
|
|
2024
Q3 | $181M | Sell |
21,773,049
-76,474
| -0.4% | -$636K | 0.04% | 347 |
|
|
2024
Q2 | $139M | Buy |
21,849,523
+21,671,365
| +12,164% | +$138M | 0.03% | 390 |
|
|
2024
Q1 | $1.08M | Buy |
178,158
+3,931
| +2% | +$23.8K | ﹤0.01% | 3499 |
|
|
2023
Q4 | $1.06M | Buy |
174,227
+105,809
| +155% | +$642K | ﹤0.01% | 3396 |
|
|
2023
Q3 | $289K | Buy |
68,418
+56,529
| +475% | +$239K | ﹤0.01% | 3999 |
|
|
2023
Q2 | $36.9K | Buy |
11,889
+6,644
| +127% | +$20.6K | ﹤0.01% | 5562 |
|
|
2023
Q1 | $7.29K | Sell |
5,245
-13,738
| -72% | -$19.1K | ﹤0.01% | 6727 |
|
|
2022
Q4 | $37.8K | Sell |
18,983
-7,592
| -29% | -$15.1K | ﹤0.01% | 5861 |
|
|
2022
Q3 | $54K | Buy |
26,575
+15,430
| +138% | +$31.4K | ﹤0.01% | 5207 |
|
|
2022
Q2 | $35K | Sell |
11,145
-1,193
| -10% | -$3.75K | ﹤0.01% | 5189 |
|
|
2022
Q1 | $51K | Sell |
12,338
-24,982
| -67% | -$103K | ﹤0.01% | 5448 |
|
|
2021
Q4 | $178K | Buy |
37,320
+26,320
| +239% | +$126K | ﹤0.01% | 4747 |
|
|
2021
Q3 | $59K | Sell |
11,000
-9,242
| -46% | -$49.6K | ﹤0.01% | 5108 |
|
|
2021
Q2 | $103K | Buy |
20,242
+9,242
| +84% | +$47K | ﹤0.01% | 4817 |
|
|
2021
Q1 | $74K | Sell |
11,000
-43,049
| -80% | -$290K | ﹤0.01% | 5196 |
|
|
2020
Q4 | $247K | Buy |
54,049
+11,786
| +28% | +$53.9K | ﹤0.01% | 4144 |
|
|
2020
Q3 | $164K | Sell |
42,263
-39,183
| -48% | -$152K | ﹤0.01% | 4096 |
|
|
2020
Q2 | $387K | Buy |
81,446
+69,106
| +560% | +$328K | ﹤0.01% | 3571 |
|
|
2020
Q1 | $43K | Buy |
12,340
+6,840
| +124% | +$23.8K | ﹤0.01% | 5057 |
|
|
2019
Q4 | $27K | Sell |
5,500
-2,128
| -28% | -$10.4K | ﹤0.01% | 5642 |
|
|
2019
Q3 | $22K | Sell |
7,628
-15,645
| -67% | -$45.1K | ﹤0.01% | 5711 |
|
|
2019
Q2 | $167K | Sell |
23,273
-18,154
| -44% | -$130K | ﹤0.01% | 4213 |
|
|
2019
Q1 | $586K | Sell |
41,427
-33,791
| -45% | -$478K | ﹤0.01% | 3270 |
|
|
2018
Q4 | $1.02M | Buy |
75,218
+25,321
| +51% | +$343K | ﹤0.01% | 2980 |
|
|
2018
Q3 | $1.11M | Sell |
49,897
-6,830
| -12% | -$152K | ﹤0.01% | 3063 |
|
|
2018
Q2 | $931K | Buy |
+56,727
| New | +$931K | ﹤0.01% | 3113 |
|